Arcadia Biosciences Inc.

NASDAQ: RKDA · Real-Time Price · USD
4.41
-0.22 (-4.75%)
At close: Aug 14, 2025, 3:40 PM
4.35
-1.36%
Pre-market: Aug 15, 2025, 08:00 AM EDT

Arcadia Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
4.24M 6.52M 20.64M 28.68M
Short-Term Investments
n/a 5.12M n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
4.06M 3.52M 932K 2.67M
Receivables
3.07M 514K 1.22M 1.37M
Inventory
904K 1.96M 2.57M 4.43M
Other Current Assets
1.03M 858K 1.21M 900K
Total Current Assets
9.24M 14.97M 25.4M 35.39M
Property-Plant & Equipment
178K 1.18M 2.55M 5.37M
Goodwill & Intangibles
39K 39K 40K 484K
Total Long-Term Assets
4.28M 4.73M 3.52M 8.53M
Total Assets
13.52M 19.7M 28.92M 43.92M
Account Payables
703K 801K 905K 1.41M
Deferred Revenue
n/a n/a n/a 64K
Short-Term Debt
155K n/a 1.01M 1.07M
Other Current Liabilities
1.68M 634K -89K -125K
Total Current Liabilities
2.56M 3.59M 4.21M 5.04M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
4.73M 3.26M 2.81M 5.46M
Total Long-Term Liabilities
4.73M 3.41M 3.81M 7.68M
Total Liabilities
7.29M 7M 8.02M 12.72M
Total Debt
155K 1.01M 2.02M 3.29M
Common Stock
65K 65K 65K 63K
Retained Earnings
-278.88M -271.84M -257.86M -226.49M
Comprehensive Income
n/a 101K n/a 0.00
Shareholders Equity
6.22M 12.84M 21.03M 31.09M
Total Investments
n/a 5.12M n/a n/a